Réseau pancanadien sur la santé des femmes et le milieu

Réseau pancanadien sur la santé des femmes et le milieu

Antidepressants linked to cancer risk in women, research bias is suggested

Text Size: Normal / Medium / Large

Antidepressants may be linked to a slight increased risk of breast and ovarian cancers, even at low doses, according to the results of a new systematic review. The increased risk is particularly stronger for women taking newer, selective-serotonin re-uptake inhibitor drugs (SSRIs) compared to older antidepressants.

The Harvard University researcher, Lisa Cosgrove, also found a possible bias in the research studies that she reviewed. In her review of 61 studies, she found that all independent studies saw a connection between antidepressants and breast cancer, while most of the company-sponsored studies did not mention any link.

Read the article in PloS ONE: Antidepressants and Breast and Ovarian Cancer Risk: A Review of the Literature and Researchers' Financial Associations with Industry

CTV reports on the bias suggested by the research: Study suggests bias in antidepressant, cancer research

See the story on the reseach in Bloomberg: Breast-Cancer Link to Paxil Drug Category Found in Antidepressant Research

Read the commentary on Pharmalot:  Antidepressants, Breast Cancer & Industry Studies

Syndicate content